Cargando…
Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide. Strokes that occur as a complication of AF are usually more severe and associated with a higher disability or morbidity and mortality rate compared with non-AF-related strokes. The risk of stroke in AF is dependent on several...
Autor principal: | Ment, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468938/ https://www.ncbi.nlm.nih.gov/pubmed/26089678 http://dx.doi.org/10.2147/VHRM.S79065 |
Ejemplares similares
-
Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
por: Dobesh, Paul P., et al.
Publicado: (2015) -
Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021) -
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015) -
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007) -
Nine‐year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation
por: Asahina, Chisa, et al.
Publicado: (2020)